NSG 533 ADVANCED PHARM EXAM 2 LATEST 2025 WITH
COMPLETE SOLUTION/ADVANCED PHARMACOLOGY FINAL EXAM
REVIEW(100% VERIFIED) GRADED A+
1. the most common symptom prompting patients to vis- pain
it primary care providers. More than 80% of patients
who visit physicians report pain. Often remains under
treated.
2. pain from a normal process that results in noxious nociceptive pain
stimuli being perceived as painful. Explained by on-
going tissue injury.
thermal, mechanical and chemical nociceptors that
engage "withdrawal" reflex followed by inflammatory
response to protect injured tissue
3. pain sensitivity due to an abnormal processing or functional pain
function of the central nervous system in response to
normal stimuli
4. Pain caused by lesions or other damage to the ner- neruopathic pain
vous system.
5. progressive deterioration of nerve function that re- Diabetic peripher-
sults in loss of sensory perception al neuropathy
6. is pain that occurs as a result of injury or surgery, acute pain
under 3 months. Poorly treated acute pain can cause
psychological stress and compromise the immune
system. Somatic acute pain is an injury to skin, bone,
joint, muscle and connective tissue. Visceral pain in-
volves injury to nerves on internal organs. Treat ag-
gressively. Examples: cut hand, menstrual cramps.
7. can be intermittent or persistent, more than 3 months. chronic pain
Main affects include a) effects on physical function
b) psychological changes c) social consequences
and d) societal consequences. Usually involving life
threatening diseases such as cancers, aids, progres-
sive neurological diseases, end stage organ failure,
dementia. Management should be multimodal with
cognitive interventions, physical manipulations, phar-
, NSG 533 ADVANCED PHARM EXAM 2 LATEST 2025 WITH
COMPLETE SOLUTION/ADVANCED PHARMACOLOGY FINAL EXAM
REVIEW(100% VERIFIED) GRADED A+
macological agents, surgical interventions, and re- bleed, high
gional or spinal anesthesia. intolerance of
non-selective
8. Painn is associated with a progressive life-threaten- NSAIDS, or
ing disease like cancer, aids, neurologic diseases, end treatment failure
stage organ failure, and dementia. Goal is pain allevi- with non-
ation and prevention. Dependence or addiction is not selective agents.
a concern. Pain not associated with life threatening NSAIDs
disease and lasting more than 6 months beyond the
healing period is referred to as "chronic nonmalignant
pain."
9. imagery, distraction, relaxation, psychotherapy,
biofeedback, cognitive behavioral therapy, support
groups, and spiritual counseling. Physical therapy,
heat, cold, water, ultrasound, TENS, massage and ther-
apeutic exercise.
10. * 1- nonopioid
* 2 - opioid for mild to moderate pain
* 3 - opioid for moderate to severe pain
11. mild pain/nonopioid analgesics such as NSAIDS or
acetaminophen w/ or w/out adjuvants (such as pre-
gablin) .. "soreness." Med examples: apap 1000mg q
6hrs, ibu600mg q6 hrs
12. Non-steroidal anti-inflammatory drugs. associated
with several clinically significant contraindications
and drug interactions. NSAIDS are equally effective in
analgesia, antipyretic and anti-inflammatory effects.
Choice should include STEPS (simplicity, tolerability,
evidence, price, safety). If patient fails therapy with an
agent from one class of NSAIDs, use of an agent from
another class is reasonable.
13. Celecoxib (Celebrex) selective agents (celecoxib)
have ideal indication in patients with high risk for GI
, NSG 533 ADVANCED PHARM EXAM 2 LATEST 2025 WITH
COMPLETE SOLUTION/ADVANCED PHARMACOLOGY FINAL EXAM
REVIEW(100% VERIFIED) GRADED A+
ological ap- proaches to pain?
chr WHO 3 step anal- gesic ladder
oni
c
ma WHO first step pain ladder
lig
na
nt
pai NSAIDs
n
W COX2 inhibitors
hat
ar
e
s
o
m
e
n
o
n
-
p
h
a
r-
m
a
c
COMPLETE SOLUTION/ADVANCED PHARMACOLOGY FINAL EXAM
REVIEW(100% VERIFIED) GRADED A+
1. the most common symptom prompting patients to vis- pain
it primary care providers. More than 80% of patients
who visit physicians report pain. Often remains under
treated.
2. pain from a normal process that results in noxious nociceptive pain
stimuli being perceived as painful. Explained by on-
going tissue injury.
thermal, mechanical and chemical nociceptors that
engage "withdrawal" reflex followed by inflammatory
response to protect injured tissue
3. pain sensitivity due to an abnormal processing or functional pain
function of the central nervous system in response to
normal stimuli
4. Pain caused by lesions or other damage to the ner- neruopathic pain
vous system.
5. progressive deterioration of nerve function that re- Diabetic peripher-
sults in loss of sensory perception al neuropathy
6. is pain that occurs as a result of injury or surgery, acute pain
under 3 months. Poorly treated acute pain can cause
psychological stress and compromise the immune
system. Somatic acute pain is an injury to skin, bone,
joint, muscle and connective tissue. Visceral pain in-
volves injury to nerves on internal organs. Treat ag-
gressively. Examples: cut hand, menstrual cramps.
7. can be intermittent or persistent, more than 3 months. chronic pain
Main affects include a) effects on physical function
b) psychological changes c) social consequences
and d) societal consequences. Usually involving life
threatening diseases such as cancers, aids, progres-
sive neurological diseases, end stage organ failure,
dementia. Management should be multimodal with
cognitive interventions, physical manipulations, phar-
, NSG 533 ADVANCED PHARM EXAM 2 LATEST 2025 WITH
COMPLETE SOLUTION/ADVANCED PHARMACOLOGY FINAL EXAM
REVIEW(100% VERIFIED) GRADED A+
macological agents, surgical interventions, and re- bleed, high
gional or spinal anesthesia. intolerance of
non-selective
8. Painn is associated with a progressive life-threaten- NSAIDS, or
ing disease like cancer, aids, neurologic diseases, end treatment failure
stage organ failure, and dementia. Goal is pain allevi- with non-
ation and prevention. Dependence or addiction is not selective agents.
a concern. Pain not associated with life threatening NSAIDs
disease and lasting more than 6 months beyond the
healing period is referred to as "chronic nonmalignant
pain."
9. imagery, distraction, relaxation, psychotherapy,
biofeedback, cognitive behavioral therapy, support
groups, and spiritual counseling. Physical therapy,
heat, cold, water, ultrasound, TENS, massage and ther-
apeutic exercise.
10. * 1- nonopioid
* 2 - opioid for mild to moderate pain
* 3 - opioid for moderate to severe pain
11. mild pain/nonopioid analgesics such as NSAIDS or
acetaminophen w/ or w/out adjuvants (such as pre-
gablin) .. "soreness." Med examples: apap 1000mg q
6hrs, ibu600mg q6 hrs
12. Non-steroidal anti-inflammatory drugs. associated
with several clinically significant contraindications
and drug interactions. NSAIDS are equally effective in
analgesia, antipyretic and anti-inflammatory effects.
Choice should include STEPS (simplicity, tolerability,
evidence, price, safety). If patient fails therapy with an
agent from one class of NSAIDs, use of an agent from
another class is reasonable.
13. Celecoxib (Celebrex) selective agents (celecoxib)
have ideal indication in patients with high risk for GI
, NSG 533 ADVANCED PHARM EXAM 2 LATEST 2025 WITH
COMPLETE SOLUTION/ADVANCED PHARMACOLOGY FINAL EXAM
REVIEW(100% VERIFIED) GRADED A+
ological ap- proaches to pain?
chr WHO 3 step anal- gesic ladder
oni
c
ma WHO first step pain ladder
lig
na
nt
pai NSAIDs
n
W COX2 inhibitors
hat
ar
e
s
o
m
e
n
o
n
-
p
h
a
r-
m
a
c
